Aster DM Healthcare Ltd
NSE:ASTERDM

Watchlist Manager
Aster DM Healthcare Ltd Logo
Aster DM Healthcare Ltd
NSE:ASTERDM
Watchlist
Price: 769.7 INR 0.5% Market Closed
Market Cap: ₹397.9B

Wall St Price Targets

ASTERDM Price Targets Summary
Aster DM Healthcare Ltd

Wall Street analysts forecast ASTERDM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASTERDM is 813.65 INR with a low forecast of 743.36 INR and a high forecast of 934.5 INR.

Lowest Forecast
Price Target
743.36 INR
3% Downside
Average Forecast
Price Target
813.65 INR
6% Upside
Highest Forecast
Price Target
934.5 INR
21% Upside
Aster DM Healthcare Ltd Competitors:
Price Targets
NVT
nVent Electric PLC
10% Upside

Revenue
Forecast

3% / Year
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
3% / Year
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 11 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 4 years is 41%.

Gross Profit
Forecast

1% / Year
Past Growth
55% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
1% / Year
Past Growth
55% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Over the last 11 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 4 years is 55%.

Operating Income
Forecast

4% / Year
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
4% / Year
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Over the last 11 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 4 years is 54%.

Pre-Tax Income
Forecast

4% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
4% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Over the last 11 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 46%.

Net Income
Forecast

36% / Year
Past Growth
-23% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
36% / Year
Past Growth
-23% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 11 years, the compound annual growth rate for Net Income has been 36%. The projected CAGR for the next 4 years is -23%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ASTERDM's stock price target?
Price Target
813.65 INR

According to Wall Street analysts, the average 1-year price target for ASTERDM is 813.65 INR with a low forecast of 743.36 INR and a high forecast of 934.5 INR.

What is the Revenue forecast for Aster DM Healthcare Ltd?
Projected CAGR
41%

Over the last 11 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 4 years is 41%.

What is the Gross Profit forecast for Aster DM Healthcare Ltd?
Projected CAGR
55%

Over the last 11 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 4 years is 55%.

What is the Operating Income forecast for Aster DM Healthcare Ltd?
Projected CAGR
54%

Over the last 11 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 4 years is 54%.

What is the Pre-Tax Income forecast for Aster DM Healthcare Ltd?
Projected CAGR
46%

Over the last 11 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 46%.

What is the Net Income forecast for Aster DM Healthcare Ltd?
Projected CAGR
-23%

Over the last 11 years, the compound annual growth rate for Net Income has been 36%. The projected CAGR for the next 4 years is -23%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett